Urwyler S, Markstein R
J Neurochem. 1986 Apr;46(4):1058-67. doi: 10.1111/j.1471-4159.1986.tb00618.x.
On the basis of affinity differences for spiperone, two binding sites for 3H-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene ([3H]ADTN) in the rat brain could be distinguished: "D3" with a low and "D4" with a high affinity for spiperone. Evidence is provided that D3 and D4 sites are related to high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Various well-known selective D1 and D2 agonists and antagonists showed potencies at these sites in agreement with this hypothesis. A comparison of the Bmax values for [3H]ADTN binding to D3 and D4 sites with the numbers of D1 receptors (labelled by [3H]SCH 23390) and of D2 receptors (labelled by [3H]spiperone), both in the striatum and in the mesolimbic system, indicated that under the conditions used for 3H-agonist binding experiments, both populations of D1 and D2 receptors were converted to their high agonist affinity states to a considerable, although different extent. In fact, when competition experiments with [3H]spiperone were performed under the conditions otherwise used for [3H]ADTN binding experiments (instead of the conditions usually used for antagonist binding), substantial shifts of the displacement curves of 3,4-dihydroxyphenylethylamine (dopamine) and ADTN toward higher affinities were observed. A comparison of the effects of various agonists and antagonists in the [3H]ADTN binding experiments and in functional tests revealed a significant correlation between their potencies at D4 binding sites and at D2 receptors modulating the release of [3H]acetylcholine from striatal slices. However, in the situation of the D1/D3 pair, when the measurement of adenylate cyclase activity was taken as a functional test for D1 receptors, agonists were more active in the binding than in the functional test, whereas for many antagonists the opposite was found. The results are discussed with regard to the classification and functional aspects of brain dopamine receptors.
基于对螺哌隆的亲和力差异,在大鼠脑中可区分出3H-2-氨基-6,7-二羟基-1,2,3,4-四氢萘([3H]ADTN)的两个结合位点:对螺哌隆亲和力低的“D3”位点和亲和力高的“D4”位点。有证据表明,D3和D4位点分别与D1和D2多巴胺受体的高激动剂亲和力状态相关。各种知名的选择性D1和D2激动剂及拮抗剂在这些位点的效力与该假设相符。将纹状体和中脑边缘系统中[3H]ADTN与D3和D4位点结合的Bmax值与D1受体(用[3H]SCH 23390标记)和D2受体(用[3H]螺哌隆标记)的数量进行比较,结果表明,在用于3H-激动剂结合实验的条件下,D1和D2受体群体均以相当程度(尽管程度不同)转变为其高激动剂亲和力状态。实际上,当在用于[3H]ADTN结合实验的条件下(而非通常用于拮抗剂结合的条件)进行[3H]螺哌隆竞争实验时,观察到3,4-二羟基苯乙胺(多巴胺)和ADTN的置换曲线向更高亲和力大幅偏移。对[3H]ADTN结合实验和功能测试中各种激动剂和拮抗剂作用的比较表明,它们在D4结合位点和调节纹状体切片中[3H]乙酰胆碱释放的D2受体上的效力之间存在显著相关性。然而,在D1/D3这一对的情况下,当将腺苷酸环化酶活性的测量作为D1受体的功能测试时,激动剂在结合实验中的活性高于功能测试,而许多拮抗剂的情况则相反。本文就脑多巴胺受体的分类和功能方面对结果进行了讨论。